Invitae Corp.
(NYSE : NVTA)

( )
NVTA PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
Loading NVTA News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
0.80%70.501.0%$928.99m
AMGNAmgen Inc.
0.90%176.130.8%$640.16m
BIIBBiogen Inc.
2.10%291.130.9%$505.62m
CELGCelgene Corporation
3.00%121.781.0%$476.20m
INCYIncyte Corporation
2.14%134.022.3%$444.12m
REGNRegeneron Pharmaceuticals, Inc.
3.34%373.051.9%$336.26m
ALXNAlexion Pharmaceuticals, Inc.
0.50%132.202.0%$304.94m
TSROTESARO, Inc.
0.28%187.4215.3%$167.36m
ILMNIllumina, Inc.
4.26%166.823.9%$151.47m
EXELExelixis, Inc.
6.46%23.095.5%$141.95m
VRTXVertex Pharmaceuticals Incorporated
3.29%88.902.6%$133.58m
CLVSClovis Oncology, Inc.
5.22%60.9216.4%$122.35m
AAgilent Technologies, Inc.
-0.16%51.661.7%$108.92m
BMRNBioMarin Pharmaceutical Inc.
4.70%91.623.9%$100.60m
ACADACADIA Pharmaceuticals Inc.
2.50%39.8519.0%$100.51m

Company Profile

Invitae Corp. engages in the provision of genetic information into mainstream medical practice. It offer tests for disorders in cardiovascular, hereditary cancer, neurology, pediatrics, and other rare diseases. The company was founded by Randal W. Scott and Sean E. George on January 13, 2010 and is headquartered in San Francisco, CA.